D
Dimitri T. Azar
Researcher at University of Illinois at Chicago
Publications - 317
Citations - 12197
Dimitri T. Azar is an academic researcher from University of Illinois at Chicago. The author has contributed to research in topics: Keratomileusis & LASIK. The author has an hindex of 55, co-authored 311 publications receiving 11024 citations. Previous affiliations of Dimitri T. Azar include Massachusetts Eye and Ear Infirmary & Ulster University.
Papers
More filters
Journal ArticleDOI
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.
Ashley Behrens,John Doyle,Lee Stern,Roy S. Chuck,Peter J. McDonnell,Dimitri T. Azar,Harminder S Dua,Milton Hom,Paul M. Karpecki,Peter R. Laibson,Michael A. Lemp,David M. Meisler,Juan Murube Del Castillo,Terrence P. O'Brien,Stephen C. Pflugfelder,Maurizio Rolando,Oliver D. Schein,Berthold Seitz,Scheffer C.G. Tseng,Gysbert van Setten,Steven E. Wilson,Samuel C. Yiu +21 more
TL;DR: A new term for dry eye disease was proposed: dysfunctional tear syndrome (DTS), and treatment recommendations were based primarily on patient symptoms and signs, based on consensus of expert advice.
Journal ArticleDOI
TFOS DEWS II Report Executive Summary
Jennifer P. Craig,J. Daniel Nelson,J. Daniel Nelson,Dimitri T. Azar,Carlos Belmonte,Anthony J. Bron,Anthony J. Bron,Sunil K. Chauhan,Cintia S. de Paiva,José Álvaro Pereira Gomes,Katherine M. Hammitt,Lyndon Jones,Jason J. Nichols,Kelly K. Nichols,Gary D. Novack,Gary D. Novack,Fiona Stapleton,Mark D. P. Willcox,James S. Wolffsohn,David A. Sullivan +19 more
TL;DR: This article presents an Executive Summary of the conclusions and recommendations of the 10-chapter TFOS DEWS II report.
Journal Article
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an american ophthalmological society thesis)
TL;DR: The finding that the potent antiangiogenic factors, angiostatin and endostatin, are colocalized with several M MPs during wound healing suggests that MMPs may be involved in the elaboration of these antiangIogenic molecules by proteolytic processing of substrates within the cornea.
Journal ArticleDOI
LASIK complications: etiology, management, and prevention.
Samir A. Melki,Dimitri T. Azar +1 more
TL;DR: By examining the etiology, management, and prevention of these complications, the refractive surgeon may be able to improve visual outcomes and prevent vision-threatening problems.
Journal ArticleDOI
Corneal neovascularization: an anti-VEGF therapy review.
TL;DR: Some of the most promising anti-VEGF therapies are reviewed, including bevacizumab, VEGF trap, siRNA, and tyrosine kinase inhibitors, for the treatment of corneal neovascularization.